BSX
Ticker
Boston Scientific Corp
Company
Devices
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
-4.7%-2.4%-4.9%-1.5%3.3%1.3%12.2%7.9%8.6%9.3%-7.7%19.9%6.7%12.3%17.6% 21.6%
Revenue Growth QoQ
Gross Margin
68.5%66.7%65.1%67.6%69.6%70.1%70.9%71.1%71.3%71.4%71.0%65.0%68.8%68.8%69.5%68.6% 68.6%
EBITDA Margin
-0.7%2.0%21.3%-43.9%11.3%5.7%5.9%15.0%23.5%24.4%23.6%10.5%19.3%22.0%24.9%23.1% 24.9%
Operating Margin
-10.9%-8.4%11.9%-53.4%1.7%-4.1%-4.4%5.3%14.2%15.3%14.1%-0.8%10.1%13.0%16.5%15.5% 17.9%
Profit Margin
-12.5%-13.6%5.8%-56.1%-1.7%-1.6%-3.2%4.1%1.1%17.0%43.8%-0.8%8.8%5.5%11.2%11.1% 14.4%
FCF / EBITDA
-871.7%33.1%43.4%-32.5%103.5%238.2%79.9%47.2%52.0%-0.3%54.4%108.5%57.4%33.7%50.6%68.3% 79.4%